IRIS - Res&Arch Institutional Research Information System - Research & Archive

FIORETTI, Maria Cristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.570
EU - Europa 2.051
AS - Asia 557
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 3
OC - Oceania 1
Totale 5.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.568
UA - Ucraina 580
IE - Irlanda 439
SE - Svezia 323
IT - Italia 225
SG - Singapore 156
HK - Hong Kong 146
DE - Germania 134
FI - Finlandia 118
VN - Vietnam 116
CN - Cina 97
RU - Federazione Russa 89
FR - Francia 34
GB - Regno Unito 29
CZ - Repubblica Ceca 17
CH - Svizzera 14
KR - Corea 13
BE - Belgio 11
GR - Grecia 11
AT - Austria 8
CI - Costa d'Avorio 8
NL - Olanda 8
UZ - Uzbekistan 8
IN - India 6
LB - Libano 6
PL - Polonia 6
TR - Turchia 5
BR - Brasile 3
EU - Europa 3
JP - Giappone 3
MX - Messico 2
BG - Bulgaria 1
DK - Danimarca 1
LK - Sri Lanka 1
LV - Lettonia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.194
Salva come PNG Salva come JPEG
Città #
Chandler 494
Dublin 439
San Mateo 271
Jacksonville 250
Boardman 165
Hong Kong 146
Dong Ket 116
Altamura 114
Medford 108
Princeton 108
Singapore 103
Des Moines 102
Wilmington 92
Lawrence 86
Ann Arbor 72
Perugia 69
Andover 62
Beijing 52
Falls Church 47
Saint Petersburg 36
Norwalk 27
Dearborn 25
Woodbridge 22
Ashburn 19
San Paolo di Civitate 19
New York 18
Brno 13
Santa Clara 12
Brussels 11
Helsinki 10
Munich 10
Fremont 9
Seoul 9
Abidjan 8
Cambridge 7
Dallas 7
Moscow 7
Den Haag 6
Shanghai 6
Auburn Hills 5
Izmir 5
Lausanne 5
Frankfurt Am Main 4
Houston 4
Nagpur 4
Nanjing 4
San Diego 4
Hanover 3
Hefei 3
Jinan 3
Kraków 3
Nürnberg 3
Tappahannock 3
Chicago 2
Lappeenranta 2
Los Angeles 2
Nanchang 2
Planegg 2
Pune 2
Rio De Janeiro 2
Wako 2
Athens 1
Boston 1
Bratislava 1
Cagliari 1
Chengdu 1
Copenhagen 1
Dambulla 1
Denver 1
Edinburgh 1
Falkenstein 1
Foligno 1
Genova 1
Groningen 1
Guangzhou 1
Lagos 1
Libertyville 1
Lisbon 1
Ludwigshafen 1
Marcallo con Casone 1
Monmouth Junction 1
Ningbo 1
Olomouc 1
Redmond 1
Riga 1
Rio de Janeiro 1
San Jose 1
Spin 1
Taupo 1
Terni 1
Tokyo 1
Turin 1
Wenzhou 1
Wuhan 1
Totale 3.279
Salva come PNG Salva come JPEG
Nome #
Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy 105
T cell apoptosis by kynurenines. 101
Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. 81
Cutting edge: Autocrine TGF-beta sustains default tolerogenesis by IDO-competent dendritic cells. 80
A retroviral peptide encoded by mutated env p15E gene is recognized by specific CD8+ T lymphocytes on drug-treated murine mastocytoma P815. 80
CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide 78
CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice 78
Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells 77
IL-12 acts selectively on CD8a- dendritic cells to enhance presentation of a tumor peptide in vivo 74
Immunogenic tumor variants induced by drug treatment of the L5178Y lymphoma: search for serologically defined antigens at the clonal level. 73
Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation 70
Cell-mediated immunity to chemically xenogenized tumors--IV. Production of lymphokine activity by, and in response to, highly immunogenic cells. 70
Antitumor activity of three nitrosourea analogues in different experimental tumor system 70
Adoptive immunotherapy of intracerebral murine lymphomas: role of different lymphoid populations. 69
Modulation of tryptophan catabolism by regulatory T cells 68
Circulating levels of IL-10 are critically related to growth and rejection patterns of murine mastocytoma cells. 67
Indoleamine 2,3-dioxygenase, transcriptional regulation and autoimmunity. 66
IL-6 inhibits the tolerogenic function of CD8 alpha+ dendritic cells expressing indoleamine 2,3-dioxygenase. 65
Dual effect of IL-4 on resistance to systemic gram-negative infection and production on TNF-alfa 65
Antilymphoma graft responses in the mouse brain: a study of T-dependent functions. 65
3H-aniracetam binds to specific recognition sites in brain membranes 62
Appearance of strong transplantation antigens in non-immunogenic lymphoma following drug-treatment in vivo. 62
Antigenic changes related to drug action. 62
Cell-mediated immunity to chemically xenogenized tumors. V. Failure of novel antigens to increase the frequency of tumor-specific cytotoxic T cells. 61
In vitro generation of primary cytotoxic lymphocytes against L5178Y leukemia antigenically altered by 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide in vivo. 61
Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. 60
CD28 induces immunostimulatory signals in dendritic cells via CD80 and CD86. 60
Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. 60
Antigenic properties of lymphoma sublines derived from a drug-treated immunogenic L5178Y leukemia. 59
Drug-induced immunogenic changes of murine leukemia cells: dissociation of onset of resistance and emergence of novel immunogenicity. 58
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 57
Cell-mediated immunity to chemically xenogenized tumors. I. Inhibition by specific antisera and H-2 association of the novel antigens. 56
Systemic adoptive immunotherapy of a highly immunogenic murine lymphoma growing in the brain. 56
Immunosuppression via tryptophan catabolism: the role of kynurenine pathway enzymes. 55
T cell apoptosis by tryptophan catabolism 54
Multiple point mutations in an endogenous retroviral gene confer high immunogenicity on a drug-treated murine 53
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 53
Cell-mediated immunity to chemically xenogenized tumors--III. Generation of monoclonal antibodies interfering with reactivity to novel antigens. 53
Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells. 52
CD40 ligand and CTLA-4 are reciprocally regulated in the Th1 cell proliferative response sustained by CD8+ dendritic cells. 52
IL-12 is both required and sufficient for initiating T-cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells 52
A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state 51
CTLA-4-Ig regulates tryptophan catabolism in vivo. 51
Towards the identification of a tolerogenic signature in IDO-competent dendritic cells 51
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 51
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 50
Chemical xenogenization of murine lymphoma cells with triazene derivatives: immunotoxicological studies. 50
Immunogenic properties of retroviral protein p15E from drug-treated murine mastocytoma P815 49
IL-23 neutralization protects mice from Gram-negative endotoxic shock. 49
Cell-mediated immunity to chemically xenogenized tumors--VI. The effect of cell treatment with retroviral env antisense oligonucleotides. 49
Tumor-specific L3T4+ and Lyt-2+ lymphocytes in mice primed to mutagenized cell variants. 49
Delayed-type hypersensitivity to tumor antigens co-expressed with immunogenic determinants induced by xenogenization. 49
CD40 ligation prevents onset of tolerogenic properties in human dendritic cells treated with CTLA-4-Ig. 49
IL-12 ACTS DIRECTLY ON DC TO PROMOTE NUCLEAR LOCALIZATION OF NF-kB AND PRIMES DC FOR IL-12 PRODUCTION 49
Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease 48
Enhanced tryptophan catabolism in the absence of the molecular adapter DAP12 48
Functional plasticity of dendritic cell subsets as mediated by CD40 versus B7 activation. 46
IL-9 protects mice from Fram-negative bacterial shock: suppression of alfa-TNF, IL-12 and gamma-IFN, and induction of IL-10. 46
IDO mediates TLR9-driven protection from experimental autoimmune diabetes 46
[In vitro cytolysis mediated by NK effectors: modification of the susceptibility of the target cell by in vivo treatment with DTIC]. 46
Intrasplenic immunization for the induction of humoral and cell-mediated immunity to nitrocellulose-bound antigen. 45
Chemical xenogenization of tumor cells. 44
The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells 44
Cutting edge: silencing suppressor of cytokine signaling 3 expression in dendritic cells turns CD28-Ig from immune adjuvant to suppressant. 44
CD40 ligation ablates the tolerogenic potential of lymphoid dendritic cells 44
Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation 43
Regulation of tumor antigen expression by drugs acting as mutagens and/or gene activators. 43
A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice 43
IL-23 and IL-12 have overlapping but distinct effects on murine dendritic cells. 41
I Chemioterapici 41
O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents. 41
Molecular and genomic aspects of xenogenizing-alkylating drugs. 41
Use of a skin test assay to determine tumor-specific CD8+ T cell reactivity 40
Susceptibility of murine lymphoma cells treated with 5-(3,3-dimethyl-1-triazenyl)-1H-imidazole-4-carboxamide to NK-mediated cytotoxicity in vitro. 40
Cytokines and tumours: problems and perspectives. 40
Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. 40
Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. 40
Functional expression of indoleamine 2,3-dioxygenase by murine CD8 alpha(+) dendritic cells. 39
IL-12 induces SDS-stable class II (alpha beta) dimers in murine dendritic cells 39
Expression of normal histocompatibility antigens in murine lymphomas treated with 5-(3,3'-dimethyl-1-triazeno)-imidazole-4-carboxamide (DTIC) in vivo. 39
Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO. 38
Endogenous retroviral gp70 genes of the murine lymphoma L5178Y: analysis of restriction fragment polymorphism upon induction of drug-mediated immunogenicity. 38
Murine plasmacytoid dendritic cells initiate the immunosuppressive pathway of tryptophan catabolism in response to CD200 receptor engagement 38
SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesis 38
Positive regulatory role of IL-12 in macrophages and modulation by IFN-gamma 37
Tryptophan catabolism generates autoimmune-preventive regulatory T cells 37
Immunogenicity of tumor peptides: importance of peptide length and stability of peptide/MHC class II complex 37
Immune system to brain signaling and vice versa: The role of tryptophan and glutamate 37
Cell-mediated immunity to chemically xenogenized tumors. II. Evidence for accessory function and self-antigen presentation by a highly immunogenic tumor variant. 37
Changes in the tumorigenic and metastatic properties of murine melanoma cells treated with a triazene derivative. 37
Intracerebral adoptive immunotherapy of a murine lymphoma antigenically altered by drug treatment in vivo. 37
Rejectionof drug-treated tumor cells inthe peritoneal cavity of mice 36
T-cell subsets, IFN-gamma production and efferent specificity in anti-parental tumor immunity induced by mouse sensitization with xenogenized variant cells. 35
Identification and immunogenic properties of an 80-kDa surface antigen on a drug-treated tumor variant: relationship to MuLV gp70. 35
Tryptophan catabolism in nonobese diabetic mice. 35
Lack of correlation between DNA-methylating activity and appearance of the immunogenic phenotype in clones of a murine lymphoma treated with mutagens. 34
Generation of monoclonal antibodies to a chemically xenogenized murine lymphoma. 34
DNA methylating activity in murine lymphoma cells xenogenized by triazene derivatives. 32
Inhibition of murine lymphoma growth by adoptive transfer of lymphocytes sensitized to a xenogenized tumor variant. 32
Rational bases of cancer immunochemotherapy: drug effects on antigen expression 32
Totale 5.174
Salva come PNG Salva come JPEG
Categoria #
all - tutte 21.794
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.794
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020418 0 0 0 3 65 25 109 3 100 48 8 57
2020/2021992 5 94 37 89 277 67 67 0 111 30 84 131
2021/2022961 15 168 9 56 73 27 16 302 18 29 74 174
2022/20231.664 128 295 15 124 145 247 1 87 556 5 47 14
2023/2024509 44 88 19 6 3 2 108 7 65 8 71 88
2024/2025223 21 125 77 0 0 0 0 0 0 0 0 0
Totale 5.378